This company has been marked as potentially delisted and may not be actively trading. Interpace Biosciences (IDXG) News Today Add Compare Share Share Headlines Stock AnalysisCompetitorsEarningsHeadlinesShort InterestTrendsBuy This Stock IDXG Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period SPDI Sells Romanian Logistics Portfolio and Ukrainian Land AssetOctober 6, 2025 | tipranks.comInterpace Biosciences presents two posters at ATA meetingSeptember 16, 2025 | msn.comInterpace Biosciences presents two posters at ATA meetingSeptember 16, 2025 | msn.comInterpace Biosciences Presented Two New Posters at the 2025 American Thyroid Association® (ATA) Annual MeetingSeptember 15, 2025 | globenewswire.comSPDI Announces Arcona Share Distribution TimetableSeptember 11, 2025 | tipranks.comPDI: 3 Reasons To Run Far Away As PossibleAugust 31, 2025 | seekingalpha.comPDI CEF: Best Time To Sell In 5 YearsAugust 5, 2025 | seekingalpha.comPDI Declares Monthly Dividend with Over 13% YieldAugust 4, 2025 | gurufocus.comPDI: Credit Offers Opportunity In An Expensive MarketJuly 29, 2025 | seekingalpha.comPDI's 13.8% Yield - Despite Coverage Shortfall, CEF Worth ConsideringJuly 29, 2025 | seekingalpha.comPDI: Get In Before The Fed Changes The TuneJuly 15, 2025 | seekingalpha.comPDI: Inflection Point AheadJune 28, 2025 | seekingalpha.comPDI: Nothing Special... YetJune 27, 2025 | seekingalpha.comPDI: Huge Income, But Please Know What You OwnJune 18, 2025 | seekingalpha.comPDI: A Decent Income InvestmentJune 17, 2025 | seekingalpha.comPDI: An Opportunity To Lock In A 14% Yield On CostMay 22, 2025 | seekingalpha.comPDO Vs. PDI: Hold PDO Amid U.S. Credit Rating DowngradeMay 22, 2025 | seekingalpha.comPDI: A Balanced Way To Get Exposure To Risky Fixed-Income PlaysMay 22, 2025 | seekingalpha.comPDI: Don't Buy This 14% YieldMay 21, 2025 | seekingalpha.comInterpace Biosciences Announces First Quarter 2025 Financial and Business ResultsMay 8, 2025 | finance.yahoo.comPDI: Your Approach Needs To ChangeApril 27, 2025 | seekingalpha.comEffective May 2, 2025, Interpace Diagnostics® Will No Longer Accept Specimens for PancraGEN®, a Molecular Diagnostic Test That Assesses Pancreatic Cyst Cancer RiskApril 24, 2025 | globenewswire.comPDI: Its Mega-Yield Party Was Over Years AgoApril 21, 2025 | seekingalpha.comPDI: A Golden Buying OpportunityApril 10, 2025 | seekingalpha.comPTY Vs. PDI: This Is The Wrong Time For PDIApril 8, 2025 | seekingalpha.comWestport Fuel Systems Reports Mixed Q4, Reveals Light-Duty Segment SaleMarch 31, 2025 | benzinga.comPIMCO March 2025 Update | PDI Gets Rich, PAXS/PFN/PHK CheaperMarch 22, 2025 | seekingalpha.comPDI Technologies Presents “The Retail Marketeers European Female Leaders in Convenience Awards”March 6, 2025 | financialpost.comFFixed Income Looks Undervalued - Cash In With 13%-Yielding PDIFebruary 14, 2025 | seekingalpha.comPDI: Buy For The Yield And FlexibilityFebruary 12, 2025 | seekingalpha.comPDI's Yield Exceeding 13% Still Looks Inexpensive As Shares Continue HigherFebruary 12, 2025 | seekingalpha.comSPDI Transfers Ukrainian Property to Arcona Fund, Strengthening Market PositionFebruary 6, 2025 | tipranks.comPDI: Buy For A Double-Digit Yield And You May Even Beat The S&P 500February 5, 2025 | seekingalpha.comInterpace Biosciences, Inc.: Interpace Biosciences Announces Preliminary Full-year and Fourth Quarter 2024 Financial and Business ResultsJanuary 31, 2025 | finanznachrichten.deInterpace Biosciences Announces Preliminary Full-year and Fourth Quarter 2024 Financial and Business ResultsJanuary 31, 2025 | globenewswire.comInterpace Biosciences, Inc.: PancraGEN Will Continue to be Offered While Interpace Re-evaluates its Previously Announced Re-structuring PlanJanuary 27, 2025 | finanznachrichten.dePancraGEN® Will Continue to be Offered While Interpace Re-evaluates its Previously Announced Re-structuring PlanJanuary 27, 2025 | globenewswire.comPaycor HCM Inc (PYCR) Partners with PDI Technologies to Enhance Workforce Management SolutionsJanuary 22, 2025 | gurufocus.comDirt Cheap 14% Yield: PDIJanuary 11, 2025 | seekingalpha.comEffective 02/07/2025, Interpace Diagnostics® to No Longer Offer PancraGEN®, a Molecular Diagnostic Test That Assesses Pancreatic Cyst Cancer RiskJanuary 9, 2025 | globenewswire.comPDI: The Premium Has Come Down On This High Yielding CEFJanuary 2, 2025 | seekingalpha.comPDI: Collecting A Double Digit Yield With A Positive OutlookJanuary 2, 2025 | seekingalpha.comSecure Property Development & Investment PLC Reports Successful AGM ResolutionsDecember 30, 2024 | tipranks.comPDO Vs. PDI: Which One Of These Double-Digit Yielding Funds Is The Better Buy?December 10, 2024 | seekingalpha.comCorpay Inc (CPAY) Announces Sale of Comdata Merchant Solutions to PDI TechnologiesDecember 2, 2024 | gurufocus.comPDI: Avoid This 14% YieldNovember 30, 2024 | seekingalpha.comPDI Vs. Peers: Double-Digit Yield But Still UnderperformingNovember 29, 2024 | seekingalpha.comPDI: Beware The Massive NAV PremiumNovember 13, 2024 | seekingalpha.comInterpace Biosciences Inc.November 9, 2024 | wsj.comInterpace Biosciences Reports Impressive Q3 2024 GrowthNovember 7, 2024 | markets.businessinsider.com Get Interpace Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for IDXG and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. IDXG Media Mentions By Week IDXG Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IDXG News Sentiment▼0.000.77▲Average Medical News Sentiment IDXG News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IDXG Articles This Week▼11▲IDXG Articles Average Week Get the Latest News and Ratings for IDXG and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Interpace Biosciences and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Labcorp News Today Quest Diagnostics News Today DaVita News Today Chemed News Today CorVel News Today Pediatrix Medical Group News Today AMN Healthcare Services News Today Cross Country Healthcare News Today Biotricity News Today INVO Fertility News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IDXG) was last updated on 10/11/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredForget AI, This Will Be the Next Big Tech BreakthroughAfter picking Nvidia in 2016, before it jumped 27,000%... Jeff Brown is back with what he believes will be ...Brownstone Research | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Interpace Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Interpace Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
